219
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

DNA Methylation Markers for Endometrial Cancer Detection in Minimally Invasive Samples: A Systematic Review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1661-1672 | Received 23 Apr 2020, Accepted 25 Jun 2020, Published online: 17 Sep 2020

References

  • Siegel RL , MillerKD , JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
  • Bray F , FerlayJ , SoerjomataramI , SiegelRL , TorreLA , JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68(6), 394–424 (2018).
  • Morice P , LearyA , CreutzbergC , Abu-RustumN , DaraiE. Endometrial cancer. Lancet387(10023), 1094–1108 (2016).
  • Lortet-Tieulent J , FerlayJ , BrayF , JemalA. International patterns and trends in endometrial cancer incidence, 1978–2013. J. Natl Cancer Inst.110(4), 354–361 (2018).
  • Brinton LA , FelixAS , McmeekinDSet al. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol. Oncol.129(2), 277–284 (2013).
  • Murali R , SoslowRA , WeigeltB. Classification of endometrial carcinoma: more than two types. Lancet Oncol.15(7), e268–278 (2014).
  • Cancer Genome Atlas Research N Kandoth C , SchultzNet al. Integrated genomic characterization of endometrial carcinoma. Nature497(7447), 67–73 (2013).
  • Clarke MA , LongBJ , DelMar Morillo A , ArbynM , Bakkum-GamezJN , WentzensenN. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Intern. Med.178(9), 1210–1222 (2018).
  • Park YR , LeeSW , KimYet al. Endometrial thickness cut-off value by transvaginal ultrasonography for screening of endometrial pathology in premenopausal and postmenopausal women. Obstet. Gynecol. Sci.62(6), 445–453 (2019).
  • Jacobs I , Gentry-MaharajA , BurnellMet al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case–control study within the UKCTOCS cohort. Lancet Oncol.12(1), 38–48 (2011).
  • Billingsley CC , KenneKA , CansinoCDet al. The use of transvaginal ultrasound in type II endometrial cancer. Int. J. Gynecol. Cancer25(5), 858–862 (2015).
  • Wang J , WieslanderC , HansenG , CassI , VasilevS , HolschneiderCH. Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers. Gynecol. Oncol.101(1), 120–125 (2006).
  • Liew PL , HuangRL , WuTIet al. Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings. Clin. Epigenetics11(1), 170 (2019).
  • Costas L , Frias-GomezJ , GuardiolaMet al. New perspectives on screening and early detection of endometrial cancer. Int. J. Cancer145(12), 3194–3206 (2019).
  • Syngal S , BrandRE , ChurchJMet al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol.110(2), 223–262 (2015).
  • Chang CC , WangHC , LiaoYPet al. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings. J. Gynecol. Oncol.29(1), e17 (2018).
  • Fiegl H , GattringerC , WidschwendterAet al. Methylated DNA collected by tampons – a new tool to detect endometrial cancer. Cancer Epidemiol. Biomarkers Prev.13(5), 882–888 (2004).
  • Kulis M , EstellerM. DNA methylation and cancer. Adv Genet70, 27–56 (2010).
  • Leygo C , WilliamsM , JinHCet al. DNA methylation as a noninvasive epigenetic biomarker for the detection of cancer. Dis. Markers2017, 3726595 (2017).
  • Qureshi SA , BashirMU , YaqinuddinA. Utility of DNA methylation markers for diagnosing cancer. Int. J. Surg.8(3), 194–198 (2010).
  • Boland PM , YurgelunMB , BolandCR. Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer J. Clin.68(3), 217–231 (2018).
  • Liberati A , AltmanDG , TetzlaffJet al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med.6(7), e1000100 (2009).
  • Moher D , LiberatiA , TetzlaffJ , AltmanDG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol.62(10), 1006–1012 (2009).
  • Huang RL , SuPH , LiaoYPet al. Integrated epigenomics analysis reveals a DNA methylation panel for endometrial cancer detection using cervical scrapings. Clin. Cancer Res.23(1), 263–272 (2017).
  • Bakkum-Gamez JN , WentzensenN , MaurerMJet al. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecol. Oncol.137(1), 14–22 (2015).
  • Sangtani A , WangC , WeaverAet al. Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection. Gynecol. Oncol.156(2), 387–392 (2020).
  • Wentzensen N , Bakkum-GamezJN , KillianJKet al. Discovery and validation of methylation markers for endometrial cancer. Int. J. Cancer135(8), 1860–1868 (2014).
  • Doufekas K , HadwinR , KandimallaRet al. GALR1 methylation in vaginal swabs is highly accurate in identifying women with endometrial cancer. Int. J. Gynecol. Cancer23(6), 1050–1055 (2013).
  • Jones A , TeschendorffAE , LiQet al. Role of DNA methylation and epigenetic silencing of HAND2 in endometrial cancer development. PLoS Med.10(11), e1001551 (2013).
  • De Strooper LM , Van ZummerenM , SteenbergenRDet al. CADM1, MAL and miR124-2 methylation analysis in cervical scrapes to detect cervical and endometrial cancer. J. Clin. Pathol.67(12), 1067–1071 (2014).
  • Kumar A . Tao brush. J. Obstet. Gynaecol. India67(4), 304–305 (2017).
  • Luttmer R , DeStrooper LM , DijkstraMGet al. FAM19A4 methylation analysis in self-samples compared with cervical scrapes for detecting cervical (pre)cancer in HPV-positive women. Br. J. Cancer115(5), 579–587 (2016).
  • Verlaat W , SnoekBC , HeidemanDaMet al. Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples. Clin. Cancer Res.24(14), 3456–3464 (2018).
  • Kurdyukov S , BullockM. DNA methylation analysis: choosing the right method. Biology (Basel)5(1), 3 (2016).
  • Quillien V , LavenuA , Karayan-TaponLet al. Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. Cancer118(17), 4201–4211 (2012).
  • Draht MX , SmitsKM , JoosteVet al. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome. Clin. Epigenetics8, 44 (2016).
  • Beltran-Garcia J , Osca-VerdegalR , Mena-MollaS , Garcia-GimenezJL. Epigenetic IVD tests for personalized precision medicine in cancer. Front. Genet.10, 621 (2019).
  • Boeckx N , OpDe Beeck K , BeyensMet al. Mutation and methylation analysis of circulating tumor dna can be used for follow-up of metastatic colorectal cancer patients. Clin. Colorectal. Cancer17(2), e369–e379 (2018).
  • Roperch JP , GrandchampB , DesgrandchampsFet al. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer. BMC Cancer16, 704 (2016).
  • Snoek BC , SplunterAPV , BleekerMCGet al. Cervical cancer detection by DNA methylation analysis in urine. Sci. Rep.9(1), 3088 (2019).
  • Van Den Helder R , Van TrommelNE , Van SplunterAP , Lissenberg-WitteBI , BleekerMCG , SteenbergenRDM. Methylation analysis in urine fractions for optimal Cin3 and cervical cancer detection. Papillomavirus Res. doi:10.1016/j.pvr.2020.100193 (2020).
  • Srivastava A , MoxleyK , RuskinR , DhanasekaranDN , ZhaoYD , RameshR. A non-invasive liquid biopsy screening of urine-derived exosomes for miRNAs as biomarkers in endometrial cancer patients. AAPS J.20(5), 82 (2018).
  • Zavesky L , JandakovaE , TurynaRet al. Evaluation of cell-free urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers. a pilot study. Pathol. Oncol. Res.21(4), 1027–1035 (2015).
  • Nair N , Camacho-VanegasO , RykunovDet al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: a prospective cross-sectional study. PLoS Med.13(12), e1002206 (2016).
  • Clarke MA , LongBJ , ShermanMEet al. A prospective clinical cohort study of women at increased risk for endometrial cancer. Gynecol. Oncol.156(1), 169–177 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.